Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Golimumab

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1 Simponi

    02 21Simponi

    03 7Simponi/Simponi Aria

    04 2Simponi/Simponi Aria

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Simponi/Simponi Aria

    Golimumab

    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    Brand Name : Simponi/Simponi Aria

    U.S.A
    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    Johnson & Johnson

    Golimumab

    Main Therapeutic Indication : Immunology

    Currency : USD

    2020 Revenue in Millions : 2,243

    2019 Revenue in Millions : 2,188

    Growth (%) : 3

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Simponi

    Golimumab

    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    Brand Name : Simponi

    Japan
    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    Mitsubishi Tanabe

    Golimumab

    Main Therapeutic Indication : Immunology

    Currency : USD

    2020 Revenue in Millions : 386

    2019 Revenue in Millions : 371

    Growth (%) : 4

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Simponi

    Golimumab

    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    Brand Name : Simponi

    U.S.A
    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    Merck

    Golimumab

    Main Therapeutic Indication : Immunology

    Currency : USD

    2020 Revenue in Millions : 838

    2019 Revenue in Millions : 830

    Growth (%) : 1

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Simponi/Simponi Aria

    Golimumab

    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    Brand Name : Simponi/Simponi Aria

    U.S.A
    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    Johnson & Johnson

    Golimumab

    Main Therapeutic Indication : Immunology

    Currency : USD

    2021 Revenue in Millions : 2,276

    2020 Revenue in Millions : 2,243

    Growth (%) : 1

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Simponi

    Golimumab

    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    Brand Name : Simponi

    Japan
    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    Mitsubishi Tanabe

    Golimumab

    Main Therapeutic Indication : Immunology

    Currency : USD

    2021 Revenue in Millions : 366

    2020 Revenue in Millions : 382

    Growth (%) : 3

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Brand Name : Simponi

    Golimumab

    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    Brand Name : Simponi

    U.S.A
    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    Merck

    Golimumab

    Main Therapeutic Indication : Immunology

    Currency : USD

    2021 Revenue in Millions : 825

    2020 Revenue in Millions : 838

    Growth (%) : -2

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Brand Name : Simponi/Simponi Aria

    Golimumab

    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    Brand Name : Simponi/Simponi Aria

    U.S.A
    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    Johnson & Johnson

    Golimumab

    Main Therapeutic Indication : Immunology

    Currency : USD

    2022 Revenue in Millions : 2,184

    2021 Revenue in Millions : 2,276

    Growth (%) : -4

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Brand Name : Simponi

    Golimumab

    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    Brand Name : Simponi

    Japan
    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    Mitsubishi Tanabe

    Golimumab

    Main Therapeutic Indication : Immunology

    Currency : USD

    2022 Revenue in Millions : 330

    2021 Revenue in Millions : 366

    Growth (%) : -10

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Brand Name : Simponi

    Golimumab

    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    Brand Name : Simponi

    U.S.A
    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    Merck & Co.

    Golimumab

    Main Therapeutic Indication : Immunology

    Currency : USD

    2022 Revenue in Millions : 706

    2021 Revenue in Millions : 825

    Growth (%) : -14

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Brand Name : Simponi/Simponi Aria

    Golimumab

    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    Brand Name : Simponi/Simponi Aria

    U.S.A
    arrow
    Medlab Asia & Asia Health
    Not Confirmed

    Johnson & Johnson

    Golimumab

    Main Therapeutic Indication : Immunology

    Currency : USD

    2023 Revenue in Millions : 2,197

    2022 Revenue in Millions : 2,184

    Growth (%) : 1

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF